Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Krailo

Showing results (101-110 of 161) with videos related to

Pageof 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology GroupStacey L Berg, Susan M Blaney, Meenakshi Devidas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
A phase I study of 90yttrium-ibritumomab-tiuxetan in children and adolescents with relapsed/refractory CD20-positive non-Hodgkin's lymphoma: a Children's Oncology Group studyErin Cooney-Qualter, Mark Krailo, Anne Angiolillo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2018
Detection of Relapse by Tumor Markers Versus Imaging in Children and Adolescents With Nongerminomatous Malignant Germ Cell Tumors: A Report From the Children's Oncology GroupAdriana Fonseca, Caihong Xia, Armando J Lorenzo, et al.
Cancer|April 12, 2011
Investigation of the insulin-like growth factor-1 signaling pathway in localized Ewing sarcoma: a report from the Children's Oncology GroupScott C Borinstein, Donald A Barkauskas, Mark Krailo, et al.
European Journal of Cancer (Oxford, England : 1990)|May 14, 2013
Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology GroupRobert E Goldsby, Timothy M Fan, Doojduen Villaluna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2007
Phase I trial and pharmacokinetic study of pemetrexed in children with refractory solid tumors: the Children's Oncology GroupSuman Malempati, H Stacy Nicholson, Joel M Reid, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 2, 2017
Ovarian Yolk Sac Tumors; Does Age Matter?Cecile Faure Conter, Caihong Xia, David Gershenson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2010
Ewing tumors that do not overexpress BMI-1 are a distinct molecular subclass with variant biology: a report from the Children's Oncology GroupAaron Cooper, John van Doorninck, Lingyun Ji, et al.
British Journal of Cancer|April 3, 2022
Predicted leukocyte telomere length and risk of germ cell tumoursShannon S Cigan, John J Meredith, Ava C Kelley, et al.
Genes, Chromosomes & Cancer|March 16, 2017
Variants in BAK1, SPRY4, and GAB2 are associated with pediatric germ cell tumors: A report from the children's oncology groupErin L Marcotte, Nathan Pankratz, James F Amatruda, et al.
Pageof 17

Showing results (101-110 of 161) with videos related to

Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology GroupStacey L Berg, Susan M Blaney, Meenakshi Devidas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
A phase I study of 90yttrium-ibritumomab-tiuxetan in children and adolescents with relapsed/refractory CD20-positive non-Hodgkin's lymphoma: a Children's Oncology Group studyErin Cooney-Qualter, Mark Krailo, Anne Angiolillo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2018
Detection of Relapse by Tumor Markers Versus Imaging in Children and Adolescents With Nongerminomatous Malignant Germ Cell Tumors: A Report From the Children's Oncology GroupAdriana Fonseca, Caihong Xia, Armando J Lorenzo, et al.
Cancer|April 12, 2011
Investigation of the insulin-like growth factor-1 signaling pathway in localized Ewing sarcoma: a report from the Children's Oncology GroupScott C Borinstein, Donald A Barkauskas, Mark Krailo, et al.
European Journal of Cancer (Oxford, England : 1990)|May 14, 2013
Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology GroupRobert E Goldsby, Timothy M Fan, Doojduen Villaluna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2007
Phase I trial and pharmacokinetic study of pemetrexed in children with refractory solid tumors: the Children's Oncology GroupSuman Malempati, H Stacy Nicholson, Joel M Reid, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 2, 2017
Ovarian Yolk Sac Tumors; Does Age Matter?Cecile Faure Conter, Caihong Xia, David Gershenson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2010
Ewing tumors that do not overexpress BMI-1 are a distinct molecular subclass with variant biology: a report from the Children's Oncology GroupAaron Cooper, John van Doorninck, Lingyun Ji, et al.
British Journal of Cancer|April 3, 2022
Predicted leukocyte telomere length and risk of germ cell tumoursShannon S Cigan, John J Meredith, Ava C Kelley, et al.
Genes, Chromosomes & Cancer|March 16, 2017
Variants in BAK1, SPRY4, and GAB2 are associated with pediatric germ cell tumors: A report from the children's oncology groupErin L Marcotte, Nathan Pankratz, James F Amatruda, et al.
Pageof 17